Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]

Affiliations

• ¹ JDRF, 26 Broadway, 14th Floor, New York, NY, 10004, USA. [email protected].
• ² Institute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Building, Barrack Road, Exeter, EX2 5DW, UK. [email protected].
• ³ Departments of Pathology and Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.
• ⁴ School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
• ⁵ Department of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
• ⁶ Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
• ⁷ Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
• ⁸ Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
• ⁹ Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland.
• ¹⁰ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
• ¹¹ Institute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Building, Barrack Road, Exeter, EX2 5DW, UK.
• ¹² Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
• ¹³ Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami, Miami, FL, USA.
• ¹⁴ Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, USA.